Scott Tria

Scott Tria is the Senior Director and Head of Medicinal Chemistry at ARTBIO, where they lead a multidisciplinary team focused on developing next-generation radioligand therapies for targeted alpha radiation delivery. Previously, they served as a Director of Medicinal Chemistry at Pfizer, overseeing collaboration and innovation in oncology and rare diseases. Scott's career includes roles at Merck as a Research Associate and at Novartis as a Research Investigator, where they contributed to global discovery chemistry across various therapeutic areas. Scott is currently pursuing a Ph.D. in Organic Chemistry at Scripps Research while holding a B.A. in Chemistry from Boston University.